Alpha Profiles · Company Profile

CONMED Corp

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/conmed-corp

Entity: Public listing published
Primary listing: NYSE: CNMD
Verification: Partially verified
Last reviewed: 2026-10-04T04:46:05.925893+00:00

Overview

Alpha's canonical identity and public leadership record for CONMED Corp.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

6 public records

Brent Lalomia

Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000816956-26-000047Apr 7, 2026

Hollie Foust

Executive Vice President, General Counsel and Corporate Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000816956-26-000047Apr 7, 2026

Patrick J. Beyer

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000816956-26-000047Apr 7, 2026

Peter K. Shagory

Executive Vice President, Strategy and Corporate Development

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000816956-26-000047Apr 7, 2026

Thomas Fistek

Chief Counsel and Assistant Corporate Secretary

State: confirmed
Effective: From Apr 7, 2026
Confidence: 94%
Evidence: CNMD DEF 14A executive officersApr 7, 2026

Todd W. Garner

Executive Vice President, Finance and Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000816956-26-000047Apr 7, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 4, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.